Efficacy and Safety of the CG-100 Intraluminal Bypass Device
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
Recruiting · NCT04184973 · Registry updated 2026-07-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of the CG-100 Intraluminal Bypass Device | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasm | Recruiting | Not applicable | 2026-07-06 | NCT04184973 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Colospan Ltd. | 1 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asklepios | Hamburg | Germany | 1 |
| CHUV | Lausanne | Switzerland | 9 |
| Colorado University Anschutz Medical Campus | Aurora | United States | 1 |
| Henry Ford Health System | Detroit | United States | 147 |
| Humanitas Research Hospital | Milan | Italy | 2 |
| Kaiser Permanente San Diego medical Center | San Diego | United States | 2 |
| Lifespan & Brown Surgical Associates | Providence | United States | 1 |
| Soroka University Medical Center | Beersheba | Israel | 1 |
| University of California Irvine | Irvine | United States | 7 |
| University of Utah Health | Salt Lake City | United States | 21 |